Core Viewpoint - The announcement indicates that the company has entered into a sales agreement with Yuan Da Jiu Fu for the sale of raw materials used in the production and sale of amino acid products and other pharmaceutical products, effective August 27, 2025 [1] Group 1 - The agreement involves Yuan Da Pharmaceutical (China) or its related companies selling raw materials to Yuan Da Jiu Fu or its related companies [1] - The focus of the sales agreement is on amino acid products and other pharmaceutical products [1]